These data indicated that miR-514b-5p promoted CRC progression by targeting CDH1 and CLDN1, and miR-514b-3p inhibited CRC development through direct targeting FZD-4 and NTN1. This evidence concerns the gene NTN1 and colorectal carcinoma.